Patents by Inventor David Brückner
David Brückner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11982625Abstract: A system for measurement is provided. The system includes a first optical path configured to supply first light pulses with a first range of wavelengths; a second optical path configured to supply second light pulses with a second range of wavelengths shorter than the first range of wavelengths; an optical I/O unit configured to emit the first light pulses and the second light pulses to a target and acquire a light from the target to detect CARS light pluses from the target by a detector; and a first phase modulating unit configured to vary phase differences between the first light pulses and the second light pulses as the first light pulses and the second light pulses are emitted via the optical I/O unit.Type: GrantFiled: June 25, 2020Date of Patent: May 14, 2024Assignee: ATONARP INC.Inventors: David Anderson, Mateusz Plewicki, Dmitriy Churin, Anand Pandurangan, Andrew Zhang, Lukas Brueckner, Prakash Sreedhar Murthy
-
Patent number: 11944407Abstract: An optical system comprises a first optical path configured to supply a first light with a first range of wavelengths; a second optical path configured to supply a second light with a second range of wavelengths shorter than the first range of wavelengths; a third optical path configured to supply a third light with a third range of wavelengths shorter than the second range of wavelengths; an optical I/O unit configured to emit the first light, the second light and the third light to a target and acquire a light from the target; a reference unit configured to split off a reference light from the third light; and a detector that includes a range of detection wavelengths shared with a CARS light and an interference light.Type: GrantFiled: April 23, 2020Date of Patent: April 2, 2024Assignee: ATONARP INC.Inventors: Lukas Brueckner, David Anderson, Prakash Sreedhar Murthy
-
Patent number: 8410090Abstract: The invention relates to heterocyclylamide-substituted thiazoles, pyrroles and thiophenes and processes for their preparation, to pharmaceutical compositions containing them, and to their use for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.Type: GrantFiled: July 1, 2006Date of Patent: April 2, 2013Assignee: AiCuris GmbH & Co. KGInventors: Holger Zimmermann, David Brueckner, Kerstin Henninger, Martin Hendrix, Martin Radtke
-
Patent number: 7977349Abstract: The invention relates to substituted quinolones and to methods for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.Type: GrantFiled: August 8, 2008Date of Patent: July 12, 2011Assignee: Aicuris GmbH & Co. KGInventors: Chantal Fuerstner, Kai Thede, Holger Zimmermann, David Brueckner, Kerstin Henninger, Dieter Lang, Rudolf Schohe-Loop
-
Patent number: 7919489Abstract: The invention relates to heterocyclylamide-substituted imidazoles and methods for their preparation, their use for the treatment and/or prophylaxis of diseases as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.Type: GrantFiled: August 20, 2007Date of Patent: April 5, 2011Assignee: Aicuris GmbH & Co. KGInventors: Holger Zimmermann, David Brueckner, Kerstin Henninger, Ulrich Rosentreter, Martin Hendrix, Joerg Keldenich, Dieter Lang, Martin Radtke, Daniela Paulsen, Armin Kern
-
Patent number: 7867992Abstract: The invention relates to substituted quinolones and to processes for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.Type: GrantFiled: January 19, 2007Date of Patent: January 11, 2011Assignee: AiCuris GmbH & Co. KGInventors: Holger Zimmermann, Rudolf Schohe-Loop, Kerstin Henninger, Dieter Lang, Kai Thede, Chantal Fuerstner, David Brueckner, Daniela Paulsen, Thomas Roelle, Johannes Koebberling, Marcus Bauser
-
Patent number: 7767704Abstract: The invention relates to the substituted imidazoles of formula (I) and to methods for producing the same, to their use in the treatment and/or prophylaxis of diseases and to their use for producing drugs for use in the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, especially against cytomegaloviruses.Type: GrantFiled: March 11, 2005Date of Patent: August 3, 2010Assignee: AiCuris GmbH & Co. KGInventors: Holger Zimmermann, David Brueckner, Dirk Heimbach, Martin Hendrix, Kerstin Henninger, Guy Hewlett, Ulrich Rosentreter, Joerg Keldenich, Dieter Lang, Martin Radtke
-
Publication number: 20100144752Abstract: The invention relates to heterocyclylamide-substituted thiazoles, pyrroles and thiophenes and to processes for preparing them, to their use for the treatment and/or prophylaxis of diseases, and to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, particularly for use as antiviral agents, especially against cytomegaloviruses.Type: ApplicationFiled: July 1, 2006Publication date: June 10, 2010Inventors: Holger Zimmermann, David Brückner, Kerstin Henninger, Martin Hendrix, Martin Radtke
-
Patent number: 7569563Abstract: The invention relates to substituted quinolones of formula (I) and to methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular against cytomegaloviruses.Type: GrantFiled: December 28, 2007Date of Patent: August 4, 2009Assignee: AiCuris GmbH & Co. HKInventors: Rudolf Schohe-Loop, Holger Zimmermann, Kerstin Henninger, Dieter Lang, Kai Thede, Chantal Fuerstner, David Brueckner
-
Publication number: 20090181996Abstract: The invention relates to substituted quinolones and to methods for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.Type: ApplicationFiled: August 8, 2008Publication date: July 16, 2009Inventors: Chantal Fuerstner, Kai Thede, Holger Zimmermann, David Brueckner, Kerstin Henninger, Dieter Lang, Rudolf Schohe-Loop
-
Publication number: 20080261964Abstract: The invention relates to substituted quinolones of formula (I) and to methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular against cytomegaloviruses.Type: ApplicationFiled: December 28, 2007Publication date: October 23, 2008Inventors: Rudolf Schohe-Loop, Holger Zimmermann, Kerstin Henninger, Dieter Lang, Kai Thede, Chantal Fuerstner, David Brueckner
-
Publication number: 20070293478Abstract: The invention relates to substituted quinolones and to processes for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.Type: ApplicationFiled: January 19, 2007Publication date: December 20, 2007Inventors: Holger Zimmermann, Rudolph Schohe-loop, Kerstin Henninger, Daniela Paulsen, Thomas Roelle, Dieter Lang, Kai Thede, Chantal Fuerstner, David Brueckner, Johannes Koebberling, Marcus Bauser
-
Patent number: 7202243Abstract: The invention relates to new substituted imidazotriazines, processes for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of cancer and neurodegenerative disorders, in particular of Parkinson's disease and of schizophrenia.Type: GrantFiled: June 25, 2003Date of Patent: April 10, 2007Assignee: Bayer HealthCare AGInventors: Martin Hendrix, David Brückner, Arno Friedl, Irene Gerlach, Volker Hinz, Jörg Keldenich, Frank Mauler, Maria Niewöhner, legal representative, Dagmar Karthaus, Karl-Heinz Schlemmer, Adrian Tersteegen, Özkan Yalkinoglu, Ulrich Niewöhner, deceased
-
Patent number: 6936609Abstract: The invention relates to new imidazotriazines, processes for their preparation, and their use for the production of medicaments for the treatment and/or prophylaxis of neurodegenerative disorders, in particular Parkinson's disease.Type: GrantFiled: June 10, 2002Date of Patent: August 30, 2005Assignee: Bayer HealthCare AGInventors: Jens-Kerim Ergüden, Marcus Bauser, Nils Burkhardt, Dietmar Flubacher, Arno Friedl, Irene Gerlach, Volker Hinz, Reinhard Jork, Paul Naab, Maria Theresia Niewöhner, Thorsten Oliver Repp, Karl-Heinz Schlemmer, Jürgen Stoltefuss, David Brückner, Martin Hendrix, Dagmar Schauss, Adrian Tersteegen, Ulrich Niewöhner